GSK3B and Alzheimer disease: GSK3β hyperactivity accelerates the molecular damage of AD by phosphorylating tau and promoting Aβ-generating processes, whereas SIRT1 activity facilitates damage control and repair by enhancing clearance of misfolded proteins and bolstering stress defences (Cardoso et al., 2016; Zhao et al., 2024).